Role of High Sensitivity CRP as an Early Biomarker of Subclinical Inflammation in Metabolic Syndrome
Indian Journal of Pharmaceutical and Biological Research · 24.07.2026 · 14 (03) · 167-172
DOI: 10.30750/ijpbr.14.3.28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical and Biological Research, online erschienen am 24.07.2026. Verfasst von Shahnawaz Hasan und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is a major public health concern characterized by central obesity, insulin resistance, dyslipidemia, and hypertension. Chronic low-grade inflammation has been recognized as a central mechanism underlying the pathogenesis of MetS. High sensitivity C-reactive protein (hs-CRP) is an established inflammatory biomarker that may help in early detection of subclinical inflammation and cardiovascular risk.
Aim
To evaluate the role of hs-CRP as an early biomarker of subclinical inflammation in metabolic syndrome.Materials and Methods: This hospital-based observational cross-sectional study was conducted at Jawaharlal Nehru Medical College, Bhagalpur, Bihar, from 2024–2026 among 180 participants. Ninety diagnosed cases of metabolic syndrome and ninety healthy controls were included. Anthropometric measurements, blood pressure, fasting blood glucose, lipid profile, and hs-CRP levels were assessed. Statistical analysis was performed using SPSS version 26.0. Student’s t-test, chi-square test, Pearson correlation analysis, and multivariate regression were used. A p-value
Zitieren
APA
Hasan, S., Bharty, R., & Shaheen, S. (2026). Role of High Sensitivity CRP as an Early Biomarker of Subclinical Inflammation in Metabolic Syndrome. Indian Journal of Pharmaceutical and Biological Research, 14(03), 167-172. https://doi.org/10.30750/ijpbr.14.3.28
Vancouver
Hasan S, Bharty R, Shaheen S. Role of High Sensitivity CRP as an Early Biomarker of Subclinical Inflammation in Metabolic Syndrome. Indian Journal of Pharmaceutical and Biological Research. 2026;14(03):167-172. doi:10.30750/ijpbr.14.3.28
BibTeX
@article{Hasan2026,
author = {Hasan, Shahnawaz and Bharty, Rolly and Shaheen, Saleha},
title = {Role of High Sensitivity CRP as an Early Biomarker of Subclinical Inflammation in Metabolic Syndrome},
journal = {Indian Journal of Pharmaceutical and Biological Research},
year = {2026},
volume = {14},
number = {03},
pages = {167--172},
doi = {10.30750/ijpbr.14.3.28}
}
EUVIMED